UnitedHealth Group reported a strong third quarter, beating analyst expectations on EPS and medical loss ratio. The company also raised its 2026 EPS guidance and hinted at conservative 2027 Street forecasts, leading to a positive market reaction despite some analyst price target adjustments.
UnitedHealth Group (UNH) shares are up due to a robust third-quarter earnings report that significantly surpassed analyst estimates for adjusted EPS and showed a better-than-expected medical loss ratio. The company further boosted investor confidence by raising its 2026 earnings per share guidance and suggesting that current 2027 Street forecasts are too conservative. This news is a strong positive catalyst for UNH, indicating solid operational performance and a favorable outlook, despite some analysts trimming price targets due to valuation concerns or broader market worries. For traders, this presents a short-term buying opportunity driven by positive earnings momentum and long-term potential based on the increased guidance, though potential regulatory changes and valuation remain key risks.